Lee, H. C., Shah, J. J., Feng, L., Manasanch, E. E., Lu, R., Morphey, A., . . . Orlowski, R. Z. (2019). A phase 1 study of filanesib, carfilzomib, and dexamethasone in patients with relapsed and/or refractory multiple myeloma. Blood Cancer J.
Stile di citazione ChicagoLee, Hans C., et al. "A Phase 1 Study of Filanesib, Carfilzomib, and Dexamethasone in Patients With Relapsed And/or Refractory Multiple Myeloma." Blood Cancer J 2019.
Citazione MLALee, Hans C., et al. "A Phase 1 Study of Filanesib, Carfilzomib, and Dexamethasone in Patients With Relapsed And/or Refractory Multiple Myeloma." Blood Cancer J 2019.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.